UK "agrees to double" adult ECMO capacity in the face of H1N1 threat
This article was originally published in Clinica
Executive Summary
The UK's only provider of adult extracorporeal membrane oxygenation (ECMO) therapy is in discussions with the government over plans by the latter to "double the number of ECMO facilities". Clinica has learnt that an agreement among "all four UK health ministers" to this effect is still "subject to discussions", but the news is a clear acknowledgement of recent evidence of the crucial role that this technology can play in managing the most severe cases of H1N1 infection.